pH-dependent vs. constant release of mesalazine in the treatment of ulcerative colitis: Do drug delivery concepts determine therapeutic efficacy? (Review).

MLA

Deissler, Helmut, et al. “PH-Dependent vs. Constant Release of Mesalazine in the Treatment of Ulcerative Colitis: Do Drug Delivery Concepts Determine Therapeutic Efficacy? (Review).” Biomedical Reports, vol. 15, no. 5, Nov. 2021, p. N.PAG. EBSCOhost, https://doi.org/10.3892/br.2021.1472.

APA

Deissler, H., Krammer, H., & Gillessen, A. (2021). pH-dependent vs. constant release of mesalazine in the treatment of ulcerative colitis: Do drug delivery concepts determine therapeutic efficacy? (Review). Biomedical Reports, 15(5), N.PAG. https://doi.org/10.3892/br.2021.1472

Chicago

Deissler, Helmut, Heinrich Krammer, and Anton Gillessen. 2021. “PH-Dependent vs. Constant Release of Mesalazine in the Treatment of Ulcerative Colitis: Do Drug Delivery Concepts Determine Therapeutic Efficacy? (Review).” Biomedical Reports 15 (5): N.PAG. doi:10.3892/br.2021.1472.